In-vitro activity of a new penem FCE 22101.

  • Daryl J. Hoban
  • Published 1989 in The Journal of antimicrobial chemotherapy


The in-vitro activity of a new penem FCE 22101 was evaluated in comparison with other antimicrobial agents against 966 aerobic and anaerobic Gram-negative and Gram-positive bacteria. FCE 22101 inhibited 90% of Enterobacteriaceae, Haemophilus influenzae, H. parainfluenzae, H. ducreyi, Neisseria gonorrhoeae, Branhamella catarrhalis, Staphylococcus aureus… (More)


  • Presentations referencing similar topics